PD Dr. med. Guido Stirnimann is a full-time hepatologist with extensive experience in the field of liver diseases. He holds board certifications in Internal Medicine and Clinical Pharmacology and Toxicology, which reflect his deep knowledge of the complex mechanisms of liver function and disease and the interplay of the liver with other organ systems, including efficacy and toxicity of drugs.
Practicing in the University Hospital Inselspital in Bern, Switzerland, for more than 10 years, Dr. Stirnimann has dedicated his career to providing exceptional care to patients suffering from liver disorders. He is an expert in the diagnosis and treatment of liver diseases, including drug-induced liver injury, autoimmune liver diseases, cirrhosis, genetic liver diseases and transplantation.
Dr. Stirnimann is also an active researcher, with many publications in leading medical journals. He is passionate about advancing the field of hepatology through clinical research and has conducted studies on drug-induced liver injury (DILI), autoimmune liver diseases, liver cirrhosis, and liver transplantation.
In addition to his clinical and research work, Dr. Stirnimann is committed to educating the next generation of medical professionals. He is actively involved in the training of medical students and postgraduate trainees, helping them develop the skills and knowledge they need to provide high-quality care to patients with liver diseases.
Dr. Stirnimann has been actively involved in the field of Drug-Induced Liver Injury (DILI) for many years. As part of his work, he has collected a significant number of DILI cases and has been involved for more than 5 years in the adjudication of DILI cases from the ProEuroDILI and the TransBioline registries. With his extensive experience and knowledge, Dr. Stirnimann is an expert in the field of DILI and is dedicated to improving our understanding of this important area of medicine.